Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

Fig. 2

Boxplot of circulating levels of biomarkers (pg/ml) in patients achieving objective response (CR/PR) according to RECIST 1.1 criteria. Baseline values for the total population (A) and according to sex (B). Changes at cycle 2 from baseline values for the total population (C) and according to sex (D)

Back to article page

Journal of Translational Medicine

ISSN: 1479-5876

Contact us